Skip to content

Pilot Trial to Evaluate PROblem Solving Therapy and APPLE Watch for College Students

Pilot Trial to Evaluate PROblem Solving Therapy and APPLE Watch for College Students (PRO-APPLE)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06333288
Enrollment
26
Registered
2024-03-27
Start date
2024-04-15
Completion date
2024-11-30
Last updated
2024-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use Disorder

Brief summary

The goals of this Pilot Trial are to test the preliminary efficacy of Problom-Solving Therapy (PST)-APPLE Watch in a 2-arm pilot Randomized Control Trial (RCT), vs education only-control to reduce alcohol use disorder symptoms and improve alcohol abstinence.

Detailed description

The aims of this study are (1) to test feasibility & acceptability of screening for AUD symptoms/alcohol misuse and recruitment among college students, and (2) to test preliminary efficacy of PST-APPLE Watch in a 2-arm pilot Randomized Control Trial (RCT).

Interventions

BEHAVIORALPST-APPLE Watch group

PST combined APPLE Watch is a tailored behavioral intervention that enables college students with AUD to successfully manage and overcome everyday life challenges influencing their alcohol intake and teach problem-solving skills.

BEHAVIORALEducation-only control group

Education-only control group receives Quit Drinking Motivation 20-min video created by the MotivationHub, followed by a 30-minute group discussion.

Sponsors

University of Illinois at Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

PRO-APPLE Study is a 2-arm pilot Randomized Control Trial (RCT).

Eligibility

Sex/Gender
ALL
Age
18 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* Male and female college students aged 18-25 yr * English-speaking * Current alcohol use more than or equal to 2 days/week via phone screening * Completion of AUDIT screening and meet criteria for (past year) mild, moderate or severe AUD during AUDADIS-5 interview * Completion of written informed consent * Interested in cutting back alcohol intake or changing his/her drinking * Baseline screening study visit

Exclusion criteria

* Participation in past 6 months in AUD or substance use treatment * Current use of medications used to treat AUD (e.g., naltrexone) * Lifetime Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 diagnosis of schizophrenia, bipolar disorder, or any psychotic disorder * Current use of psychoactive drugs * Not currently enrolled in college * Not interested in cutting back alcohol intake or changing his/her drinking * Pregnancy or intention to become pregnant

Design outcomes

Primary

MeasureTime frameDescription
Alcohol abstinenceUp to 3 monthsParticipants will be monitored for 3 months to assess alcohol abstinence by blood alcohol content.

Secondary

MeasureTime frameDescription
Change in Reasons for drinking at 3 months.Baseline, 3 monthsMeasured by Drinking Motives Questionnaire Revised (DMQ-R).
Change in the quality of life at 3 months.Baseline, 3 months.Measured by Quality of Life Scale (QOLS).
Percent heavy drinking days at 3 months.Baseline, 3 months.Measured by 90-day Timeline Followback (TLFB).
Percent binge drinking days at 3 months.Baseline, 3 months.Measured by 90-day Timeline Followback (TLFB).
Percent days abstinence at 3 months.Baseline, 3 months.Measured by 90-day Timeline Followback (TLFB).
Change in AUD severity at 3 months.Baseline, 3 months.Measured by Alcohol Use Disorder and Associated Disabilities Interview Schedule-5(AUDADIS-5). Change in AUD severity from baseline to 3 months.
Change in AUD frequency status.Baseline, 3 months.Measured by AUDIT. Participants will be monitored for up to 3 months. This is the number of participants who screen positive for AUD.
Change in Alcohol-related negative consequences at 3 months.Baseline, 3 months.Measured by Rutgers Alcohol Problem Index (RAPI).
Change in Alcohol use at 3 months.Baseline, 3 months.Measured by 90-day Timeline Followback (TLFB).
Change in negative affect at 3 months.Baseline, 3 monthsMeasured by Positive and Negative Affect Schedule (PANAS).
Change in positive affect at 3 months.Baseline, 3 months.Measured by Positive and Negative Affect Schedule (PANAS).
Change in Cognitive performance (executive cognitive ability and attention and working memory) at 3 months.Baseline, 3 months.Compensatory Measured by Compensatory Cognitive Strategies Scale

Other

MeasureTime frameDescription
Participant Retention3 months.Participant retention will be assessed throughout the study by monitoring the proportion of the sample retained at 3-month.
Protocol Acceptability3 months.PI or a trained research team member will conduct semi-structured interviews 3-month post-intervention with each participant and will adapt the semi-structured interview guide approach from the previous research study (Study named: Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor \[SPEAC\] and DEDICATE study).
Intervention Acceptability3 months.Measured by the Client Counseling Satisfaction Scale(CCSS).
Intervention Fidelity3 months.Participant adherence to the PST-APPLE intervention schedule will be assessed by documented session attendance.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026